Booz Allen Hamilton Holding

BAH · NYSE

$74.97+$0.91 (+1.23%)TodayMarket closed ·
Prev close $74.06

BAH analyst rating

HoldConsensus of 12 analysts over the last 12 months. 25% rate it a buy.
  • Strong buy0
  • Buy3
  • Hold6
  • Underperform2
  • Sell1

12-month price target · 16 analysts

Average $86.03 (+14.8% upside)

Low
$68.68
Now
$74.97
High
$147.00

Upgrades and downgrades

The latest rating actions, newest first

BAH analyst upgrades, downgrades and rating actions
FirmDateActionRating
Truist SecuritiesOct 8, 2026UpgradeHold → Buy
CitigroupOct 7, 2026MaintainsNeutral
JefferiesOct 7, 2026MaintainsHold
TD CowenOct 6, 2026MaintainsHold
JefferiesSep 1, 2026InitiatesHold
CitigroupJul 29, 2026MaintainsNeutral
UBSJul 27, 2026MaintainsNeutral
Cantor FitzgeraldJul 23, 2026MaintainsOverweight
B of A SecuritiesJul 20, 2026MaintainsUnderperform
Goldman SachsJul 14, 2026MaintainsSell

The case for and against

Updated Oct 17, 2026

Bull case

Booz Allen Hamilton is viewed positively because its low valuation, strong free-cash-flow generation, and durable defense/intelligence franchise provide downside support even after sharp underperformance. Despite a 6.4% revenue decline in FY4Q26 to $2.78b, adjusted EBITDA margin expanded to 11.1%, adjusted EPS beat expectations at $1.78, and backlog rose 3.1% to $38b, while NTM RPO coverage improved to 61% of FY2027 midpoint guidance. The outlook is further supported by FY2027 guidance for $11.2b-$11.7b revenue, $825m-$925m FCF, and sequential improvement through the year, suggesting civil weakness can be offset by stronger national security demand and better execution.

Bear case

Booz Allen Hamilton is facing a weakened fundamental backdrop as Civil-exposed businesses slow under new administrative priorities, while cancellations or disruptions of leading cost-plus contracts, especially in Civil IT programs, threaten revenue visibility. Headcount and hiring growth disruptions, combined with capital-allocation and merger-accretion risks from staffing-focused names, suggest execution may remain uneven even before broader demand softness is considered. Margin pressure from government pricing initiatives and competitive bidding, alongside slower-than-expected contract-award ramps and potential federal budget disruptions, supports a view that the stock should trade without its historical premium as growth and restructuring weigh on FY2028E expectations.

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.